1. A novel modulation of structural and functional changes of mouse bone marrow derived dendritic cells (BMDCs) by interleukin-2(IL-2)
   Xiaofang Hu et al, 2015, Human Vaccines & Immunotherapeutics CrossRef
2. Landscape of Manufacturing Process of ATMP Cell Therapy Products for Unmet Clinical Needs
   Ralf Pörtner et al, 2018, Stem Cells in Clinical Practice and Tissue Engineering CrossRef
3. Phase I Clinical Trial Using Autologous Ex Vivo Expanded NK Cells and Cytotoxic T Lymphocytes for Cancer Treatment in Vietnam
   Nguyen Thanh Liem et al, 2019, International Journal of Molecular Sciences CrossRef
4. Ex�vivo expansion of human peripheral blood natural killer cells and cytotoxic T lymphocytes from lung cancer patients
   Hoang Nhung et al, 2018, Oncology Letters CrossRef
5. Effect of Aging on NK Cell Population and Their Proliferation at Ex Vivo Culture Condition
   Sellamuthu Subbanna Gounder et al, 2018, Analytical Cellular Pathology CrossRef
6. Single‐Use Bioreactors for Manufacturing of Immune Cell Therapeutics
   Ralf Pörtner et al, 2019, Single‐Use Technology in Biopharmaceutical Manufacture CrossRef
7. Evaluating the Safety and Quality of Life of Colorectal Cancer Patients Treated by Autologous Immune Enhancement Therapy (AIET) in Vinmec International Hospitals
   Hoang-Phuong Nguyen et al, 2022, International Journal of Molecular Sciences CrossRef
8. Ex vivo-expanded natural killer cells kill cancer cells more effectively than ex vivo-expanded γδ T cells or αβ T cells
   Xuewen Deng et al, 2014, International Immunopharmacology CrossRef